Rechallenge With Switching Immune Checkpoint Inhibitors Following Autoimmune Myocarditis in a Patient With Lynch Syndrome.

Eslinger, Cody; Walden, Daniel; Barry, Timothy; Shah, Shimoli; Samadder, Niloy Jewel; Bekaii-Saab, Tanios S

Eslinger, Cody; Walden, Daniel; Barry, Timothy; Shah, Shimoli; Samadder, Niloy Jewel; Bekaii-Saab, Tanios S.

Afiliación

Eslinger C; Department of Internal Medicine, Mayo Clinic, Phoenix, Arizona.
Walden D; Department of Hematology and Oncology, Mayo Clinic, Phoenix, Arizona.
Barry T; Department of Cardiovascular Medicine, Mayo Clinic, Phoenix, Arizona.
Shah S; Department of Cardiovascular Medicine, Mayo Clinic, Phoenix, Arizona.
Samadder NJ; Department of Gastroenterology and Hepatology, Mayo Clinic, Phoenix, Arizona.
Bekaii-Saab TS; Department of Hematology and Oncology, Mayo Clinic, Phoenix, Arizona.

J Natl Compr Canc Netw ; 21(9): 894-899, 2023 09.

Article en En | MEDLINE | ID: mdl-37673116

Asunto(s)

Neoplasias Colorrectales Hereditarias sin Poliposis; Miocarditis; Humanos; Inhibidores de Puntos de Control Inmunológico/efectos adversos; Neoplasias Colorrectales Hereditarias sin Poliposis/tratamiento farmacológico; Inestabilidad de Microsatélites; Miocarditis/tratamiento farmacológico; Miocarditis/etiología; Nivolumab/efectos adversos

Palabras clave

Lynch syndrome; MSI high malignancies; autoimmune myocarditis; immune checkpoint inhibitors; metastatic gastric cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Colorrectales Hereditarias sin Poliposis / Miocarditis Tipo de estudio: Etiology_studies Límite: Humans Idioma: En Revista: J Natl Compr Canc Netw Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google